[HTML][HTML] Diffusion of subsidized ACTs in accredited drug shops in Tanzania: determinants of stocking and characteristics of early and late adopters

PS Larson, P Yadav, S Alphs, J Arkedis… - BMC Health Services …, 2013 - Springer
Background Many households in sub-Saharan Africa utilize the private sector as a primary
source of treatment for malaria episodes. Expanding access to effective treatment in private …

[HTML][HTML] A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug …

JM Cohen, O Sabot, K Sabot, M Gordon, I Gross… - BMC Health Services …, 2010 - Springer
Background Millions of individuals with malaria-like fevers purchase drugs from private
retailers, but artemisinin-based combination therapies (ACTs), the only effective treatment in …

[HTML][HTML] Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing …

S Alba, MW Hetzel, C Goodman, A Dillip, J Liana… - Malaria journal, 2010 - Springer
Background To improve access to treatment in the private retail sector a new class of outlets
known as accredited drug dispensing outlets (ADDO) was created in Tanzania. Tanzania …

[HTML][HTML] Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania

P Yadav, JL Cohen, S Alphs, J Arkedis, PS Larson… - Malaria Journal, 2012 - Springer
Abstract Background The Affordable Medicines Facility for malaria (AMFm) is a pilot supra-
national subsidy program that aims to increase access and affordability of artemisinin …

[HTML][HTML] Understanding private sector antimalarial distribution chains: a cross-sectional mixed methods study in six malaria-endemic countries

B Palafox, E Patouillard, S Tougher, C Goodman… - PloS one, 2014 - journals.plos.org
Background Private for-profit outlets are important treatment sources for malaria in most
endemic countries. However, these outlets constitute only the last link in a chain of …

[HTML][HTML] Malaria treatment in the retail sector: knowledge and practices of drug sellers in rural Tanzania

MW Hetzel, A Dillip, C Lengeler, B Obrist, JJ Msechu… - BMC public health, 2008 - Springer
Abstract Background Throughout Africa, the private retail sector has been recognised as an
important source of antimalarial treatment, complementing formal health services. However …

Retail supply of malaria‐related drugs in rural Tanzania: risks and opportunities

C Goodman, S Patrick Kachur, S Abdulla… - Tropical medicine & …, 2004 - Wiley Online Library
Objectives To characterize availability of fever and malaria medicines within the retail sector
in rural Tanzania, assess the likely public health implications, and identify opportunities for …

[HTML][HTML] Increasing access to subsidized artemisinin-based combination therapy through accredited drug dispensing outlets in Tanzania

E Rutta, B Kibassa, B McKinnon, J Liana… - Health research policy …, 2011 - Springer
Abstract Background In Tanzania, many people seek malaria treatment from retail drug
sellers. The National Malaria Control Program identified the accredited drug dispensing …

[HTML][HTML] Antimalarial market composition and performance in Nigeria and the Democratic Republic of Congo: results from 2013 ACTwatch outlet surveys

M Littrell, R Sudoi, J Archer, J Ngigi… - Malaria …, 2014 - malariajournal.biomedcentral.com
Background Nigeria and the Democratic Republic of Congo (DRC) together account for one-
third of the estimated global total of malaria cases and 40% of malaria deaths. Improving …

[HTML][HTML] Saleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT)

FM Ringsted, IS Massawe, MM Lemnge, IC Bygbjerg - Malaria journal, 2011 - Springer
Abstract Background Artemether-lumefantrine (ALu) replaced sulphadoxine-pymimethamine
(SP) as the official first-line anti-malarial in Tanzania in November 2006. So far, artemisinin …